1. Home
  2. News
  3. Chimeric Therapeutics Limited
  4. New CLTX CAR technology patent protection in India & Israel
More Chimeric Therapeutics Limited news
Chimeric Therapeutics LimitedASX: CHM

New CLTX CAR technology patent protection in India & Israel

Apr 28, 2023 at 12:04 AM EDT · Issued by Chimeric Therapeutics Limited

Filed with ASX · Apr 28, 2023 at 12:04 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/new-cltx-car-technology-patent-protection-in-india-and-israel

Chimeric Therapeutics Limited on 6ix

Story so far

  • Dosing complete in 3rd cohort of CHM 1101 (CLTX CAR T) trialDec 22, 2022
  • Patent received in Japan for CLTX CAR technologyAug 3, 2022
  • Encouraging data from 2nd dose cohort in CLTX CAR T trialFeb 8, 2022

Earlier from Chimeric Therapeutics

  • Phase 1B brain cancer clinical trial approved for initiationApr 25, 2023
  • CHM 1101 GBM Abstract Accepted for ASCO 2023 PresentationApr 3, 2023
  • Positive pre-IND meeting with FDA for Phase 1 CAR T studyMar 20, 2023
  • Fourth dose cohort initiated in CHM 1101 Phase 1 trialMar 2, 2023
  • Appendix 4D and Half Year ReportFeb 28, 2023

Later from Chimeric Therapeutics

  • Board & management commit to $1M placement and proposed SPPMay 15, 2023
  • SPP offer documents issued to shareholdersMay 22, 2023
  • Launch of new Phase 1B Glioblastoma clinical trialJun 4, 2023
  • Share purchase plan completedJun 23, 2023
  • CHM secures up to A$12.6m through SPP and placementsJun 23, 2023
All Chimeric Therapeutics news releases↗

Follow Chimeric Therapeutics into a list and get an email when it puts out news.

Follow Chimeric Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer